Table 5.

Comparison of Osteoporotic and Non-Osteoporotic COPD Groups

Variables	Osteoporotic COPD Patients (n= 12)	Non-Osteoporotic COPD Patients (n=18)	p-value
Age#	65.00 (41–79)	65.00 (44–78)	0.723
BMI#	24.69 (19.66–29.38)	27.07 (24.91–34.11)	0.002
Smoking: pack/year#	37.75 (0–128)	27.50 (0–140)	0.285
ESH#	25.50 (8–53)	31.50 (11–99)	0.267
ICS duration (month)#	36.00 (12.00–120.00)	60.00 (24.00–132.00)	0.305
ICS dose (μg)#	720 (320–800)	800 (160–1000)	0.917
Cumulative dose	642,400 (292,000–292,000)	788,400 (233,600–3,212,000)	0.305
Disease duration (year)#	5 (2–10)	6 (2–20)	0.415
FEV1 (L) #	1.28 (0.55–2.35)	1.52 (0.75–2.16)	0.491
FEV1 (%)#	51.00 (30.00–85.00)	48.50 (28.00–75.00)	0.573
FVC (L) #	2.03 (0.70–2.70)	2.08 (0.9–3.20)	0.950
FVC (%)#	57.00 (33.00–72.00)	55.00 (31.00–88.00)	0.642
FEV1/FVC#	63.90 (43.00–85.80)	68.65 (47.30–84.30)	0.642
PEF (L) #	3.13 (0.88–4.75)	2.43 (1.43–5.87)	0.790
PEF (%)#	40.00 (19.00–61.00)	33.00 (18.00–77.00)	0.799
IC (L) #	2.32 (1.44–3.15)	2.52 (1.15–3.01)	0.897
IC (%)#	75.00 (53.00–122.00)	61.00 (46.00–116.00)	0.252
MVV (L) #	31.30 (18.80–56.70)	37.60 (17.10–92.10)	0.767
MVV (%)#	30.00 (21.00–50.00)	41.00 (18.00–53.00)	0.494

Note: Data were presented as ^#median (minimum–maximum).